Literature DB >> 30455829

Incidence of Atrial Fibrosis in Non-Valvular Atrial Fibrillation Patients and its Impact on Recurrence after Pulmonary Vein Antral Isolation.

Ayman Morttada Abd El Moteleb1, John Kamel Zarif2, Ahmed Nabil Ali2.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia; it affects 1%-2% of the general population [1]. Many studies demonstrated an association between atrial fibrosis and AF [2]. There is increasing evidence that even in patients with lone AF; the AF is an arrhythmic manifestation of a structural atrial disease which has been described as fibrotic atrial cardiomyopathy [3]. It is unknown whether the presence of atrial fibrosis has any impact on post pulmonary vein antrum isolation outcome. PURPOSE OF THE STUDY: This study aims to determine the incidence of atrial fibrosis in patients with non-valvular AF and its impact on recurrence after pulmonary vein antrum isolation. PATIENTS AND METHODS: This study included twenty eight consecutive patients referred for first-time pulmonary vein antrum isolation for the treatment of symptomatic recurrent non-valvular AF not responding to medical treatment, Isolation of the pulmonary veins antra was performed using three dimensional electroanatomical mapping, detailed voltage map was done in the right and left atrium, before ablation and Low-voltage zones were identified. Follow up of the patients was done for 6 months after the procedure to detect recurrence of AF.
RESULTS: Left atrium fibrosis was present in 6 (21.4%) cases, right atrium fibrosis was present only in 1 (3.6%) case and recurrence of atrial fibrillation after 6 months occurred in 12 (42.9%) cases. AF burden was significantly higher in the recurrence group [50.33 ±19.7 (48) (hour/month)] as compared to no recurrence group [29.5 ± 6.99 (32) (hour/month)] with P-value 0.002 and the incidence of left atrium fibrosis was significantly higher in the recurrence group as compared to no recurrence group with P-value 0.024. The only significant predictors of recurrence were the presence of left atrium fibrosis (OR 10.71, 95% CI 1.05 to 109.78; P=0.046) and AF burden (OR 1.14, 95% CI 1.02 to 1.27; P=0.023). The only significant predictor of the presence of left atrium fibrosis was AF burden (OR 1.06, 95% CI 1.01 to 1.13; P=0.031).
CONCLUSIONS: The presence of the atrial fibrosis in the left atrium is an independent predictor of atrial fibrillation recurrence after pulmonary vein antrum isolation after 6 months without left atium substrate modification.

Entities:  

Keywords:  AF; Atrial Fibrosis; Electrophysiology; Radiofrequency Ablation

Year:  2018        PMID: 30455829      PMCID: PMC6207236          DOI: 10.4022/jafib.1773

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  8 in total

1.  A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.

Authors:  Uğur Canpolat; Ali Oto; Tuncay Hazirolan; Hamza Sunman; Hikmet Yorgun; Levent Şahiner; Ergün Bariş Kaya; Kudret Aytemir
Journal:  J Cardiovasc Electrophysiol       Date:  2014-12-08

2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

3.  Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections.

Authors:  Takanori Yamaguchi; Takeshi Tsuchiya; Yasutsugu Nagamoto; Koji Miyamoto; Kenta Murotani; Kaoru Okishige; Naohiko Takahashi
Journal:  Europace       Date:  2013-09-26       Impact factor: 5.214

4.  Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

Review 5.  Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.

Authors:  Raed A Joundi; Lauren E Cipriano; Luciano A Sposato; Gustavo Saposnik
Journal:  Stroke       Date:  2016-03-29       Impact factor: 7.914

Review 6.  Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.

Authors:  Hans Kottkamp
Journal:  Eur Heart J       Date:  2013-06-11       Impact factor: 29.983

7.  Bipolar electrogram amplitudes in the left atrium are related to local conduction velocity in patients with atrial fibrillation.

Authors:  Koji Miyamoto; Takeshi Tsuchiya; Sumito Narita; Takanori Yamaguchi; Yasutsugu Nagamoto; Shin-ichi Ando; Kiyoshi Hayashida; Yoshito Tanioka; Naohiko Takahashi
Journal:  Europace       Date:  2009-11-11       Impact factor: 5.214

8.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

  8 in total
  2 in total

1.  The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden.

Authors:  Szilvia Herczeg; Joseph Galvin; John J Keaney; Edward Keelan; Roger Byrne; Claire Howard; Laszlo Geller; Gabor Szeplaki
Journal:  Cardiol Res Pract       Date:  2020-08-13       Impact factor: 1.866

2.  Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation.

Authors:  Zefeng Wang; Liting Cheng; Junmeng Zhang; Zhuo Liang; Ruiqing Dong; Fei Hang; Xinlu Wang; Ziyu Wang; Yongquan Wu; Jie Du
Journal:  Med Sci Monit       Date:  2020-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.